Search

Lisa V. Cook

Examiner (ID: 13949, Phone: (571)272-0816 , Office: P/1678 )

Most Active Art Unit
1642
Art Unit(s)
1641, 1642, 1678, 1677
Total Applications
1370
Issued Applications
805
Pending Applications
161
Abandoned Applications
418

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17316017 [patent_doc_number] => 20210405065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => METHOD FOR INCREASING CELL SUSCEPTIBILITY TO COMPLEMENT- MEDIATED LYSIS [patent_app_type] => utility [patent_app_number] => 17/479453 [patent_app_country] => US [patent_app_date] => 2021-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11635 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/479453
METHOD FOR INCREASING CELL SUSCEPTIBILITY TO COMPLEMENT- MEDIATED LYSIS Sep 19, 2021 Pending
Array ( [id] => 17506574 [patent_doc_number] => 20220099677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => METHODS FOR DETECTING AND QUANTIFYING MEMBRANE-ASSOCIATED PROTEINS [patent_app_type] => utility [patent_app_number] => 17/469533 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23196 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/469533
METHODS FOR DETECTING AND QUANTIFYING MEMBRANE-ASSOCIATED PROTEINS Sep 7, 2021 Abandoned
Array ( [id] => 18369133 [patent_doc_number] => 11649287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Checkpoint blockade and microsatellite instability [patent_app_type] => utility [patent_app_number] => 17/465096 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 11389 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465096 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465096
Checkpoint blockade and microsatellite instability Sep 1, 2021 Issued
Array ( [id] => 17299526 [patent_doc_number] => 20210395365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY [patent_app_type] => utility [patent_app_number] => 17/465101 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465101 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465101
Checkpoint blockade and microsatellite instability Sep 1, 2021 Issued
Array ( [id] => 19259030 [patent_doc_number] => 12019080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Methods and compositions for diagnosis and prognosis of renal injury and renal failure [patent_app_type] => utility [patent_app_number] => 17/409168 [patent_app_country] => US [patent_app_date] => 2021-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49114 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409168 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/409168
Methods and compositions for diagnosis and prognosis of renal injury and renal failure Aug 22, 2021 Issued
Array ( [id] => 17412624 [patent_doc_number] => 20220047528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => METHODS OF INHIBITING LYSINE-SPECIFIC DEMETHYLASE 1 (LSD-1) [patent_app_type] => utility [patent_app_number] => 17/385508 [patent_app_country] => US [patent_app_date] => 2021-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385508 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/385508
METHODS OF INHIBITING LYSINE-SPECIFIC DEMETHYLASE 1 (LSD-1) Jul 25, 2021 Abandoned
Array ( [id] => 17201391 [patent_doc_number] => 20210341486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => METHODS AND KITS FOR PREDICTING PROGNOSIS OF CANCER USING SOLUBLE MORTALIN IN BLOOD [patent_app_type] => utility [patent_app_number] => 17/378829 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378829 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/378829
METHODS AND KITS FOR PREDICTING PROGNOSIS OF CANCER USING SOLUBLE MORTALIN IN BLOOD Jul 18, 2021 Abandoned
Array ( [id] => 18567461 [patent_doc_number] => 20230257795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => METHOD FOR DETERMINING AMOUNTS OF NAD METABOLITES FROM SAMPLE AND METHODS AND USES RELATED THERETO [patent_app_type] => utility [patent_app_number] => 18/004790 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004790 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004790
METHOD FOR DETERMINING AMOUNTS OF NAD METABOLITES FROM SAMPLE AND METHODS AND USES RELATED THERETO Jul 6, 2021 Pending
Array ( [id] => 18355072 [patent_doc_number] => 11643462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-09 [patent_title] => Checkpoint blockade and microsatellite instability [patent_app_type] => utility [patent_app_number] => 17/354653 [patent_app_country] => US [patent_app_date] => 2021-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 11355 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17354653 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/354653
Checkpoint blockade and microsatellite instability Jun 21, 2021 Issued
Array ( [id] => 17170408 [patent_doc_number] => 20210324078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY [patent_app_type] => utility [patent_app_number] => 17/354656 [patent_app_country] => US [patent_app_date] => 2021-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11357 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17354656 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/354656
Checkpoint blockade and microsatellite instability Jun 21, 2021 Issued
Array ( [id] => 18740923 [patent_doc_number] => 20230349901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => Methods For Identification of Cognate Pairs of Ligands and Receptors [patent_app_type] => utility [patent_app_number] => 18/002114 [patent_app_country] => US [patent_app_date] => 2021-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26941 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002114 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002114
Methods For Identification of Cognate Pairs of Ligands and Receptors Jun 17, 2021 Pending
Array ( [id] => 18421596 [patent_doc_number] => 20230176060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => TUMOUR BIOMARKERS FOR IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/921822 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30630 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17921822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/921822
TUMOUR BIOMARKERS FOR IMMUNOTHERAPY May 12, 2021 Pending
Array ( [id] => 18568309 [patent_doc_number] => 20230258645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/923241 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923241 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923241
ANTXR1 AS A BIOMARKER OF IMMUNOSUPPRESSIVE FIBROBLAST POPULATIONS AND ITS USE FOR PREDICTING RESPONSE TO IMMUNOTHERAPY May 6, 2021 Pending
Array ( [id] => 18584046 [patent_doc_number] => 20230266307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => BIOINFORMATICS [patent_app_type] => utility [patent_app_number] => 17/923526 [patent_app_country] => US [patent_app_date] => 2021-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923526 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923526
BIOINFORMATICS May 5, 2021 Pending
Array ( [id] => 18421607 [patent_doc_number] => 20230176071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => ARRAYS AND METHODS FOR IDENTIFYING BINDING SITES ON A PROTEIN [patent_app_type] => utility [patent_app_number] => 17/923904 [patent_app_country] => US [patent_app_date] => 2021-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923904 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923904
ARRAYS AND METHODS FOR IDENTIFYING BINDING SITES ON A PROTEIN May 5, 2021 Pending
Array ( [id] => 18486179 [patent_doc_number] => 20230213521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => BIOMARKERS FOR DETECTION OF LUNG CANCER [patent_app_type] => utility [patent_app_number] => 17/921275 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17921275 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/921275
BIOMARKERS FOR DETECTION OF LUNG CANCER Apr 27, 2021 Pending
Array ( [id] => 18437475 [patent_doc_number] => 20230184770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => Exosome Analysis And Brain Tumors [patent_app_type] => utility [patent_app_number] => 17/920356 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -129 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920356 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/920356
Exosome Analysis And Brain Tumors Apr 20, 2021 Pending
Array ( [id] => 17201395 [patent_doc_number] => 20210341490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => METHODS FOR DETECTING AND/OR MEASURING ANTI-DRUG ANTIBODIES, IN PARTICULAR TREATMENT-EMERGENT ANTI-DRUG ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/229119 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229119 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/229119
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies Apr 12, 2021 Issued
Array ( [id] => 17143059 [patent_doc_number] => 20210311072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => Absolute Quantitation of Proteins and Protein Modifications by Mass Spectrometry with Multiplexed Internal Standards [patent_app_type] => utility [patent_app_number] => 17/223858 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223858 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/223858
Absolute Quantitation of Proteins and Protein Modifications by Mass Spectrometry with Multiplexed Internal Standards Apr 5, 2021 Abandoned
Array ( [id] => 17143026 [patent_doc_number] => 20210311039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => SYSTEM AND SENSOR ARRAY [patent_app_type] => utility [patent_app_number] => 17/215923 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215923 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/215923
System and sensor array Mar 28, 2021 Issued
Menu